A triple-therapy combination inhaler for moderate to very severe COPD

Description

In this Product Explainer, Prof Christine Jenkins, Head of the Respiratory Group at The George Institute for Global Health; and Senior Staff Specialist in Thoracic Medicine at Concord Hospital explains the role of a triple-therapy combination, pressurised meter dose inhaler for adults with moderate to very severe COPD. (4 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof William Kemp

A/Prof William Kemp

Cardiovascular Risk and Fatty Liver Disease

Dr Ryan De Cruz

Dr Ryan De Cruz

Importance of Early & Effective Treatment of Mild to Moderate Acne

Prof Merlin Thomas

Prof Merlin Thomas

SGLT2s and Renal Protection

Dr Adam Nelson

Dr Adam Nelson

CV Medications – Practical Strategies to Improve Compliance

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Christine Jenkins

expert

Prof Christine Jenkins

Respiratory Physician; Head, Respiratory Group, The George Institute for Global Health

Date published: 24 January 2022